Daily Roundup

PME.ASX CCP.ASX GQG.ASX FPH.ASX SDF.ASX

Pro Medicus Lands Major U.S. Healthcare Contract

Pro Medicus has secured a substantial seven-year deal worth A$25 million with Valley Health, a Virginia-based healthcare system operating six hospitals. The contract centers on the company's Visage 7 imaging platform, which will be rolled out across the cloud. Valley Health will gain access to Visage 7's full suite of tools—the Viewer, Workflow, Open Archive, and Cardiology Imaging capabilities—allowing the health system to migrate its legacy PACS archive and integrate images directly into its electronic health records. The implementation kicks off in Q1 2027. The deal is structured on a transaction-based model with upside potential, and the company remains upbeat about growing demand for its "Full Stack +1" solution across all market segments.

Credit Corp Bolsters Portfolio with HSBC Credit Card Book

Credit Corp Group is making a strategic move into credit card receivables, agreeing to acquire HSBC's Australian credit card run-off book for approximately A$150 million. The transaction is subject to regulatory approval and should wrap up early in 2027. More importantly, this acquisition is prompting Credit Corp to revise its FY27 guidance upwards. The company now expects PDL acquisitions between A$300-380 million, gross lending volumes of A$445-495 million, net profit after tax of A$112-120 million, and earnings per share of 164-176 cents. While the receivables will have a shorter duration than Credit Corp's typical charged-off debt portfolio, the deal is expected to hit the company's hurdle return targets.

Fisher & Paykel Healthcare Signals Strong Momentum

Fisher & Paykel Healthcare is painting an optimistic picture for its 2027 financial year. The company expects first-half revenue of approximately A$1.24 billion and net profit after tax of around A$280 million—representing 14% growth in operating revenue and a robust 24% jump in net profit compared to the same period last year. Looking at the full year, the company has updated its outlook to project operating revenue between A$2.47-2.57 billion and net profit after tax in the A$525-565 million range. Management anticipates an overall improvement in gross margins and is maintaining its assumptions around current global tariff rates and policies.

GQG Partners Navigates Mixed Half-Year Results

Investment manager GQG Partners reported a somewhat subdued first half of 2026, though the company is holding steady. Funds under management totaled A$156 billion as of June 30, with net outflows of A$15.1 billion—partially cushioned by A$7.2 billion in investment gains. Net revenue dipped 1.4% to A$397.2 million, while net operating income fell 1.7% to A$301.8 million. On the brighter side, average funds under management grew 1.0% to A$164.5 billion, and management fee revenue climbed 1.9% thanks to higher average FUM and improved fee realization rates. The company declared a second-quarter dividend of USD 0.0362 per share, representing a 90% payout ratio of distributable earnings. GQG remains focused on long-term absolute returns and capital preservation despite market headwinds.

Steadfast Group Trading Halted

Trading in Steadfast Group securities has been temporarily paused by ASX Supervision, effective immediately. The company has not disclosed details about the reason for the pause or when trading might resume.